Author:
Galgano Letizia,Hutt Daphna,Mekelenkamp Hilda
Abstract
AbstractThe HSCT (haematopoietic stem cell transplant) is a particular treatment for many haematological and non-haematological diseases. Broadly, there are three different categories of transplantation, autologous, allogeneic and syngeneic, which can be applied to most disease scenarios. Haematopoietic stem cells can be derived from the bone marrow, peripheral blood and umbilical cord blood. HSCT treatment can be divided into separate phases that start with the harvest of the stem cells and passing through the conditioning, aplasia and engraftment until the recovery of the haematopoietic functions. HSCT is indicated in many diseases, and these indications depend on numerous factors such as the disease type, stage and response to previous treatment. This chapter includes transplant in primary immunodeficiency in children, haemoglobinopathies as well as inherited bone marrow failure and inborn errors of metabolism.
Funder
European Society for Blood and Marrow Transplantation
Publisher
Springer International Publishing